D2 DOPAMINE RECEPTOR GENOTYPE AND CEREBROSPINAL-FLUID HOMOVANILLIC-ACID, 5-HYDROXYINDOLEACETIC ACID AND 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN ALCOHOLICS IN FINLAND AND THE UNITED-STATES

被引:92
作者
GOLDMAN, D
DEAN, M
BROWN, GL
BOLOS, AM
TOKOLA, R
VIRKKUNEN, M
LINNOILA, M
机构
[1] NIAAA, CLIN STUDIES LAB, BETHESDA, MD 20892 USA
[2] NCI, PROGRAM RESOURCES INC, BETHESDA, MD 20892 USA
[3] UNIV HELSINKI, DEPT PSYCHIAT, SF-00100 HELSINKI 10, FINLAND
关键词
ALCOHOLISM; DOPAMINE; SEROTONIN; GENETIC ASSOCIATION; IMPULSIVITY;
D O I
10.1111/j.1600-0447.1992.tb03279.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
If a genetic association between the D2 dopamine receptor genotype and alcoholism is mediated by altered dopamine function, then a stronger association might be found in alcoholics who are deviant in indices of dopamine function and by comparing alcoholics to nonalcoholics matched for ethnic origin. Therefore, we evaluated the D2/TaqI polymorphism in 29 impulsive violent alcoholic Finns, 17 nonimpulsive violent alcoholic Finns and 36 Finnish controls free of mental disorders, alcoholism and substance abuse. In 37 of the alcoholics, we measured cerebrospinal fluid (CSF) homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol. There was no relationship between D2/Taq 1 genotype and concentrations of these monoamine metabolites in this group, which exhibits lower CSF HVA and 5-HIAA as compared to controls. There was also no genotypic difference between Finnish alcoholics and nonalcoholic controls. The lack of relationship between D2/Taq1 genotype and HVA concentration was replicated in 24 Caucasian alcoholics in the United States.
引用
收藏
页码:351 / 357
页数:7
相关论文
共 39 条
  • [1] EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE
    ANDEN, NE
    RUBENSON, A
    FUXE, K
    HOKFELT, T
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) : 627 - &
  • [2] ASTON CE, 1990, AM J HUM GENET, V46, P879
  • [3] ALLELIC ASSOCIATION OF HUMAN DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM
    BLUM, K
    NOBLE, EP
    SHERIDAN, PJ
    MONTGOMERY, A
    RITCHIE, T
    JAGADEESWARAN, P
    NOGAMI, H
    BRIGGS, AH
    COHN, JB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15): : 2055 - 2060
  • [4] ASSOCIATION OF THE AL ALLELE OF THE D2 DOPAMINE RECEPTOR GENE WITH SEVERE ALCOHOLISM
    BLUM, K
    NOBLE, EP
    SHERIDAN, PJ
    FINLEY, O
    MONTGOMERY, A
    RITCHIE, T
    OZKARAGOZ, T
    FITCH, RJ
    SADLACK, F
    SHEFFIELD, D
    DAHLMANN, T
    HALBARDIER, S
    NOGAMI, H
    [J]. ALCOHOL, 1991, 8 (05) : 409 - 416
  • [5] BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156
  • [6] AGGRESSION IN HUMANS CORRELATES WITH CEREBROSPINAL-FLUID AMINE METABOLITES
    BROWN, GL
    GOODWIN, FK
    BALLENGER, JC
    GOYER, PF
    MAJOR, LF
    [J]. PSYCHIATRY RESEARCH, 1979, 1 (02) : 131 - 139
  • [7] CLONINGER CR, 1991, JAMA-J AM MED ASSOC, V266, P1833
  • [8] THE DOPAMINE-D2 RECEPTOR LOCUS AS A MODIFYING GENE IN NEUROPSYCHIATRIC DISORDERS
    COMINGS, DE
    COMINGS, BG
    MUHLEMAN, D
    DIETZ, G
    SHAHBAHRAMI, B
    TAST, D
    KNELL, E
    KOCSIS, P
    BAUMGARTEN, R
    KOVACS, BW
    LEVY, DL
    SMITH, M
    BORISON, RL
    EVANS, DD
    KLEIN, DN
    MACMURRAY, J
    TOSK, JM
    SVERD, J
    GYSIN, R
    FLANAGAN, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (13): : 1793 - 1800
  • [9] CONNEALLY PM, 1991, ARCH GEN PSYCHIAT, V48, P664
  • [10] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
    CREESE, I
    BURT, DR
    SNYDER, SH
    [J]. SCIENCE, 1976, 192 (4238) : 481 - 483